{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:53:55Z","timestamp":1788407635388,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":70,"publisher":"Springer New York","isbn-type":[{"value":"9781493928736","type":"print"},{"value":"9781493928743","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-1-4939-2874-3_1","type":"book-chapter","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T10:31:14Z","timestamp":1436783474000},"page":"1-10","source":"Crossref","is-referenced-by-count":49,"title":["Carbohydrate-Based Vaccines: An Overview"],"prefix":"10.1007","author":[{"given":"Julia","family":"H\u00fctter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Lepenies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1038\/nm1209","volume":"11","author":"SA Plotkin","year":"2005","unstructured":"Plotkin SA (2005) Vaccines: past, present and future. Nat Med 11:S5\u2013S11","journal-title":"Nat Med"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nri2494","volume":"9","author":"AJ Pollard","year":"2009","unstructured":"Pollard AJ, Perrett KP, Beverley PC (2009) Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat Rev Immunol 9:213\u2013220","journal-title":"Nat Rev Immunol"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","volume":"12","author":"B Pulendran","year":"2011","unstructured":"Pulendran B, Ahmed R (2011) Immunological mechanisms of vaccination. Nat Immunol 12:509\u2013517","journal-title":"Nat Immunol"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0264-410X(99)00434-X","volume":"18","author":"MR Hilleman","year":"2000","unstructured":"Hilleman MR (2000) Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine 18:1436\u20131447","journal-title":"Vaccine"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0140-6736(11)60440-6","volume":"378","author":"R Rappuoli","year":"2011","unstructured":"Rappuoli R, Black S, Lambert PH (2011) Vaccine discovery and translation of new vaccine technology. Lancet 378:360\u2013368","journal-title":"Lancet"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.38.1.73","volume":"38","author":"M Heidelberger","year":"1923","unstructured":"Heidelberger M, Avery OT (1923) The Soluble Specific Substance of Pneumococcus. J Exp Med 38:73\u201379","journal-title":"J Exp Med"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1084\/jem.40.3.301","volume":"40","author":"M Heidelberger","year":"1924","unstructured":"Heidelberger M, Avery OT (1924) The Soluble Specific Substance of Pneumococcus : Second Paper. J Exp Med 40:301\u2013317","journal-title":"J Exp Med"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1183\/09031936.01.00084401","volume":"18","author":"A Ortqvist","year":"2001","unstructured":"Ortqvist A (2001) Pneumococcal vaccination: current and future issues. Eur Respir J 18:184\u2013195","journal-title":"Eur Respir J"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.54.1.51","volume":"54","author":"R Dubos","year":"1931","unstructured":"Dubos R, Avery OT (1931) Decomposition of the Capsular Polysaccharide of Pneumococcus Type Iii by a Bacterial Enzyme. J Exp Med 54:51\u201371","journal-title":"J Exp Med"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.54.1.73","volume":"54","author":"OT Avery","year":"1931","unstructured":"Avery OT, Dubos R (1931) The Protective Action of a Specific Enzyme against Type Iii Pneumococcus Infection in Mice. J Exp Med 54:73\u201389","journal-title":"J Exp Med"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.micro.62.081307.162944","volume":"65","author":"J Yother","year":"2011","unstructured":"Yother J (2011) Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu Rev Microbiol 65:563\u2013581","journal-title":"Annu Rev Microbiol"},{"key":"1_CR12","first-page":"17","volume":"319","author":"JJ Mond","year":"2008","unstructured":"Mond JJ, Kokai-Kun JF (2008) The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens. Curr Top Microbiol Immunol 319:17\u201340","journal-title":"Curr Top Microbiol Immunol"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.carres.2003.07.008","volume":"338","author":"A Weintraub","year":"2003","unstructured":"Weintraub A (2003) Immunology of bacterial polysaccharide antigens. Carbohyd Res 338:2539\u20132547","journal-title":"Carbohyd Res"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1084\/jem.52.4.573","volume":"52","author":"T Francis","year":"1930","unstructured":"Francis T, Tillett WS (1930) Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharide. J Exp Med 52:573\u2013585","journal-title":"J Exp Med"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.52.4.561","volume":"52","author":"WS Tillett","year":"1930","unstructured":"Tillett WS, Francis T (1930) Serological Reactions in Pneumonia with a Non-Protein Somatic Fraction of Pneumococcus. J Exp Med 52:561\u2013571","journal-title":"J Exp Med"},{"issue":"Suppl 5","key":"1_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1469-0691.2012.03943.x","volume":"18","author":"JD Grabenstein","year":"2012","unstructured":"Grabenstein JD, Klugman KP (2012) A century of pneumococcal vaccination research in humans. Clin Microbiol Infect 18(Suppl 5):15\u201324","journal-title":"Clin Microbiol Infect"},{"key":"1_CR17","first-page":"294","volume":"119","author":"K Landsteiner","year":"1921","unstructured":"Landsteiner K (1921) \u00dcber heterogenetisches antigen und hapten. XV. Mitteilung \u00fcber antigene. Biochem Z 119:294\u2013306","journal-title":"Biochem Z"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"J Davies","year":"2010","unstructured":"Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74:417\u2013433","journal-title":"Microbiol Mol Biol Rev"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1016\/j.febslet.2006.03.053","volume":"580","author":"JF Vliegenthart","year":"2006","unstructured":"Vliegenthart JF (2006) Carbohydrate based vaccines. FEBS Lett 580:2945\u20132950","journal-title":"FEBS Lett"},{"issue":"Suppl 2","key":"1_CR20","doi-asserted-by":"publisher","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","volume":"30","author":"C Vipond","year":"2012","unstructured":"Vipond C, Care R, Feavers IM (2012) History of meningococcal vaccines and their serological correlates of protection. Vaccine 30(Suppl 2):B10\u2013B17","journal-title":"Vaccine"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.micpath.2013.02.003","volume":"57","author":"NM Caesar","year":"2013","unstructured":"Caesar NM, Myers KA, Fan X (2013) Neisseria meningitidis serogroup B vaccine development. Microb Pathog 57:33\u201340","journal-title":"Microb Pathog"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.4161\/hv.7.8.16270","volume":"7","author":"R Yogev","year":"2011","unstructured":"Yogev R, Tan T (2011) Meningococcal disease: the advances and challenges of meningococcal disease prevention. Hum Vaccin 7:828\u2013837","journal-title":"Hum Vaccin"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1473-3099(08)70152-X","volume":"8","author":"SK Morris","year":"2008","unstructured":"Morris SK, Moss WJ, Halsey N (2008) Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis 8:435\u2013443","journal-title":"Lancet Infect Dis"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1542\/peds.85.4.643","volume":"85","author":"ED Shapiro","year":"1990","unstructured":"Shapiro ED, Berg AT (1990) Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine. Pediatrics 85:643\u2013647","journal-title":"Pediatrics"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1086\/649541","volume":"50","author":"JA Crump","year":"2010","unstructured":"Crump JA, Mintz ED (2010) Global trends in typhoid and paratyphoid Fever. Clin Infect Dis 50:241\u2013246","journal-title":"Clin Infect Dis"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s100960050361","volume":"18","author":"L Hessel","year":"1999","unstructured":"Hessel L, Debois H, Fletcher M et al (1999) Experience with Salmonella typhi Vi capsular polysaccharide vaccine. Eur J Clin Microbiol Infect Dis 18:609\u2013620","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0065-3101(24)00217-2","volume":"32","author":"DJ Barrett","year":"1985","unstructured":"Barrett DJ (1985) Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Adv Pediatr 32:139\u2013158","journal-title":"Adv Pediatr"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.4161\/hv.19158","volume":"8","author":"R Simon","year":"2012","unstructured":"Simon R, Levine MM (2012) Glycoconjugate vaccine strategies for protection against invasive Salmonella infections. Hum Vaccin Immunother 8:494\u2013498","journal-title":"Hum Vaccin Immunother"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s281-001-8166-x","volume":"23","author":"EE Adderson","year":"2001","unstructured":"Adderson EE (2001) Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations. Springer Semin Immunopathol 23:387\u2013403","journal-title":"Springer Semin Immunopathol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-immunol-030409-101159","volume":"28","author":"FY Avci","year":"2010","unstructured":"Avci FY, Kasper DL (2010) How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol 28:107\u2013130","journal-title":"Annu Rev Immunol"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1146\/annurev.iy.13.040195.003255","volume":"13","author":"JJ Mond","year":"1995","unstructured":"Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Annu Rev Immunol 13:655\u2013692","journal-title":"Annu Rev Immunol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1034\/j.1600-065X.2000.00607.x","volume":"176","author":"Q Vos","year":"2000","unstructured":"Vos Q, Lees A, Wu ZQ et al (2000) B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176:154\u2013170","journal-title":"Immunol Rev"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","volume":"119","author":"D Goldblatt","year":"2000","unstructured":"Goldblatt D (2000) Conjugate vaccines. Clin Exp Immunol 119:1\u20133","journal-title":"Clin Exp Immunol"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.1016\/j.vaccine.2011.09.078","volume":"29","author":"JM Skinner","year":"2011","unstructured":"Skinner JM, Indrawati L, Cannon J et al (2011) Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine 29:8870\u20138876","journal-title":"Vaccine"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1016\/j.vaccine.2011.04.053","volume":"29","author":"M Knuf","year":"2011","unstructured":"Knuf M, Kowalzik F, Kieninger D (2011) Comparative effects of carrier proteins on vaccine-induced immune response. Vaccine 29:4881\u20134890","journal-title":"Vaccine"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/35100512","volume":"1","author":"WR Heath","year":"2001","unstructured":"Heath WR, Carbone FR (2001) Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1:126\u2013134","journal-title":"Nat Rev Immunol"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1469-0691.2003.00530.x","volume":"9","author":"G Ada","year":"2003","unstructured":"Ada G, Isaacs D (2003) Carbohydrate-protein conjugate vaccines. Clin Microbiol Infect 9:79\u201385","journal-title":"Clin Microbiol Infect"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1471-2334-12-207","volume":"12","author":"C Weil-Olivier","year":"2012","unstructured":"Weil-Olivier C, van der Linden M, de Schutter I et al (2012) Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 12:207","journal-title":"BMC Infect Dis"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd3012","volume":"9","author":"RD Astronomo","year":"2010","unstructured":"Astronomo RD, Burton DR (2010) Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov 9:308\u2013324","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1586\/erv.12.18","volume":"11","author":"F Rebeaud","year":"2012","unstructured":"Rebeaud F, Bachmann MF (2012) Immunization strategies for Clostridium difficile infections. Expert Rev Vaccines 11:469\u2013479","journal-title":"Expert Rev Vaccines"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1586\/erv.13.9","volume":"12","author":"MA Monteiro","year":"2013","unstructured":"Monteiro MA, Ma Z, Bertolo L et al (2013) Carbohydrate-based Clostridium difficile vaccines. Expert Rev Vaccines 12:421\u2013431","journal-title":"Expert Rev Vaccines"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.chembiol.2011.03.009","volume":"18","author":"MA Oberli","year":"2011","unstructured":"Oberli MA, Hecht ML, Bindsch\u00e4dler P et al (2011) A possible oligosaccharide-conjugate vaccine candidate for Clostridium difficile is antigenic and immunogenic. Chem Biol 18:580\u2013588","journal-title":"Chem Biol"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"9713","DOI":"10.1021\/ja401410y","volume":"135","author":"CE Martin","year":"2013","unstructured":"Martin CE, Broecker F, Oberli MA et al (2013) Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. J Am Chem Soc 135:9713\u20139722","journal-title":"J Am Chem Soc"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrmicro1537","volume":"5","author":"JE Cutler","year":"2007","unstructured":"Cutler JE, Deepe GS Jr, Klein BS (2007) Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 5:13\u201328","journal-title":"Nat Rev Microbiol"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nrmicro3156","volume":"11","author":"A Cassone","year":"2013","unstructured":"Cassone A (2013) Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol 11:884\u2013891","journal-title":"Nat Rev Microbiol"},{"key":"1_CR46","volume-title":"Essentials of glycobiology","author":"R Cummings","year":"2009","unstructured":"Cummings R, Turco S (2009) Parasitic Infections. In: Varki A et al (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor (NY), New York","edition":"2"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.abb.2004.04.004","volume":"426","author":"AK Nyame","year":"2004","unstructured":"Nyame AK, Kawar ZS, Cummings RD (2004) Antigenic glycans in parasitic infections: implications for vaccines and diagnostics. Arch Biochem Biophys 426:182\u2013200","journal-title":"Arch Biochem Biophys"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1017\/S0031182012000273","volume":"139","author":"A van Diepen","year":"2012","unstructured":"van Diepen A, Van der Velden NS, Smit CH et al (2012) Parasite glycans and antibody-mediated immune responses in Schistosoma infection. Parasitology 139:1219\u20131230","journal-title":"Parasitology"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE et al (2014) Human schistosomiasis. Lancet 383:2253\u20132264","journal-title":"Lancet"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00018-013-1491-1","volume":"71","author":"DM Walker","year":"2014","unstructured":"Walker DM, Oghumu S, Gupta G et al (2014) Mechanisms of cellular invasion by intracellular parasites. Cell Mol Life Sci 71:1245\u20131263","journal-title":"Cell Mol Life Sci"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nature00937","volume":"418","author":"L Schofield","year":"2002","unstructured":"Schofield L, Hewitt MC, Evans K et al (2002) Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418:785\u2013789","journal-title":"Nature"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/chem.200400934","volume":"11","author":"YU Kwon","year":"2005","unstructured":"Kwon YU, Soucy RL, Snyder DA et al (2005) Assembly of a series of malarial glycosylphosphatidylinositol anchor oligosaccharides. Chemistry 11:2493\u20132504","journal-title":"Chemistry"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1021\/jo015521z","volume":"66","author":"MC Hewitt","year":"2001","unstructured":"Hewitt MC, Seeberger PH (2001) Solution and solid-support synthesis of a potential leishmaniasis carbohydrate vaccine. J Org Chem 66:4233\u20134243","journal-title":"J Org Chem"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1021\/cb600086b","volume":"1","author":"X Liu","year":"2006","unstructured":"Liu X, Siegrist S, Amacker M et al (2006) Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate. ACS Chem Biol 1:161\u2013164","journal-title":"ACS Chem Biol"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tim.2007.03.003","volume":"15","author":"DJ Vigerust","year":"2007","unstructured":"Vigerust DJ, Shepherd VL (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15:211\u2013218","journal-title":"Trends Microbiol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/31514","volume":"393","author":"R Wyatt","year":"1998","unstructured":"Wyatt R, Kwong PD, Desjardins E et al (1998) The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705\u2013711","journal-title":"Nature"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature10373","volume":"477","author":"LM Walker","year":"2011","unstructured":"Walker LM, Huber M, Doores KJ et al (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477:466\u2013470","journal-title":"Nature"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","volume":"109","author":"H Mouquet","year":"2012","unstructured":"Mouquet H, Scharf L, Euler Z et al (2012) Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A 109:E3268\u2013E3277","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nsmb.2594","volume":"20","author":"L Kong","year":"2013","unstructured":"Kong L, Lee JH, Doores KJ et al (2013) Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol 20:796\u2013803","journal-title":"Nat Struct Mol Biol"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1016\/j.vaccine.2011.09.009","volume":"29","author":"J Heimburg-Molinaro","year":"2011","unstructured":"Heimburg-Molinaro J, Lum M, Vijay G et al (2011) Cancer vaccines and carbohydrate epitopes. Vaccine 29:8802\u20138826","journal-title":"Vaccine"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4155\/fmc.11.193","volume":"4","author":"R Hevey","year":"2012","unstructured":"Hevey R, Ling CC (2012) Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies. Future Med Chem 4:545\u2013584","journal-title":"Future Med Chem"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","volume":"117","author":"BA Cobb","year":"2004","unstructured":"Cobb BA, Wang Q, Tzianabos AO et al (2004) Polysaccharide processing and presentation by the MHCII pathway. Cell 117:677\u2013687","journal-title":"Cell"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.smim.2013.05.005","volume":"25","author":"FY Avci","year":"2013","unstructured":"Avci FY, Li X, Tsuji M et al (2013) Carbohydrates and T cells: a sweet twosome. Semin Immunol 25:146\u2013151","journal-title":"Semin Immunol"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/j.1462-5822.2005.00591.x","volume":"7","author":"BA Cobb","year":"2005","unstructured":"Cobb BA, Kasper DL (2005) Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol 7:1398\u20131403","journal-title":"Cell Microbiol"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"17481","DOI":"10.1073\/pnas.0903313106","volume":"106","author":"S Gallorini","year":"2009","unstructured":"Gallorini S, Berti F, Mancuso G et al (2009) Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides. Proc Natl Acad Sci U S A 106:17481\u201317486","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/08923970903292663","volume":"32","author":"B Lepenies","year":"2010","unstructured":"Lepenies B, Seeberger PH (2010) The promise of glycomics, glycan arrays and carbohydrate-based vaccines. Immunopharmacol Immunotoxicol 32:196\u2013207","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1126\/science.1095209","volume":"305","author":"V Verez-Bencomo","year":"2004","unstructured":"Verez-Bencomo V, Fernandez-Santana V, Hardy E et al (2004) A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 305:522\u2013525","journal-title":"Science"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chembiol.2014.01.002","volume":"21","author":"C Anish","year":"2014","unstructured":"Anish C, Schumann B, Pereira CL et al (2014) Chemical biology approaches to designing defined carbohydrate vaccines. Chem Biol 21:38\u201350","journal-title":"Chem Biol"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1021\/ja401164s","volume":"135","author":"Y Yang","year":"2013","unstructured":"Yang Y, Oishi S, Martin CE et al (2013) Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteria. J Am Chem Soc 135:6262\u20136271","journal-title":"J Am Chem Soc"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nchembio.1650","volume":"10","author":"M Cavallari","year":"2014","unstructured":"Cavallari M, Stallforth P, Kalinichenko A et al (2014) A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice. Nat Chem Biol 10:950\u2013956","journal-title":"Nat Chem Biol"}],"container-title":["Methods in Molecular Biology","Carbohydrate-Based Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-2874-3_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T19:24:16Z","timestamp":1717961056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-2874-3_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9781493928736","9781493928743"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-2874-3_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}